Option Care Health price target lowered to $35 from $41 at Barrington

Barrington lowered the firm’s price target on Option Care Health to $35 from $41 and keeps an Outperform rating on the shares. The company reported solid Q3 results but the stock fell 15% on fiscal 2024 margin headwinds and acquisition commentary, the analyst tells investors in a research note. Yesterday’s comments appeared to represent a material step up in emphasis from 90 days ago with the implication being that there could be meaningful action on the M&A front over the next several months, the analyst tells investors in a research note. The firm thinks this issue is likely to weigh on Option Care’s valuation for the foreseeable future.